George Makar

George Makar

Company: Food and Drug Administration

Job title: Medical Officer


Drug Development for NASH: A Regulatory Perspective 8:00 am

• Understanding the importance of early clinical development and proof-of-concept trials • Describing the rationale for the choice of the surrogate endpoint reasonably likely to predict clinical benefit • Identifying the endpoints used to characterize the confirmation of clinical benefitRead more

day: Day Two

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.